MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lrr.2025.100548

Медицинская библиотека · Leukemia research reports · 2025

Pediatric-inspired (R3) vs. Adult salvage (FA) chemotherapy in relapsed adolescents and young adults (AYA) acute lymphoblastic leukemia (ALL): A comparative outcome analysis.

Lamine Chokri Ben, Alshehri Mohammed, Samhan Lara, Hassan Maha Abdullah, Elhassan Tusneem Ahmed M, Elfakih Riad, Alfraih Feras Abdulaziz, Ahmed Syed Osman, Hanbali Amr

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Relapsed acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA) remains a high-risk scenario with limited evidence guiding optimal salvage regimens. Pediatric-inspired protocols have improved frontline outcomes in AYA-ALL, yet their applicability in relapse remains undefined.

OBJECTIVE

To compare the clinical efficacy and toxicity of the pediatric-based UKALL R3 protocol versus the adult salvage fludarabine/cytarabine (FA) regimen in relapsed Philadelphia-negative AYA-ALL.

METHODS

A retrospective cohort study was conducted at a single tertiary care center including 77 patients aged 14-40 years with relapsed AYA-ALL. Seventeen patients received the R3 regimen and sixty received the FA protocol. Primary endpoints included complete remission (CR) rate and overall survival (OS). Secondary endpoints assessed minimal residual disease (MRD) response, transplantation rates, and treatment-related toxicities.

RESULTS

Baseline characteristics were comparable, though the FA cohort had older patients and higher-risk cytogenetics. CR rates were 60 % in R3 versus 76.3 % in FA (p=0.1). Median follow-up of 4 years showed numerically superior OS with R3 (53 % vs. 30.8 %, p=0.8). Toxicities varied: febrile neutropenia and hepatotoxicity were more frequent with FA, while mucositis and peripheral neuropathy predominated in R3. Infection-related deaths occurred less often in R3 (12.5 % vs. 25 %).

CONCLUSION

The pediatric-inspired R3 and adult-based FA regimens yielded similar survival and remission rates in relapsed AYA-ALL. Distinct toxicity profiles suggest that treatment selection should be individualized. Larger, prospective studies are warranted to validate the role of pediatric salvage protocols in this challenging population.

Для цитирования: Lamine Chokri Ben, Alshehri Mohammed, Samhan Lara, Hassan Maha Abdullah, Elhassan Tusneem Ahmed M, Elfakih Riad, Alfraih Feras Abdulaziz, Ahmed Syed Osman, Hanbali Amr. Pediatric-inspired (R3) vs. Adult salvage (FA) chemotherapy in relapsed adolescents and young adults (AYA) acute lymphoblastic leukemia (ALL): A comparative outcome analysis.. Leukemia research reports. 2025. DOI: 10.1016/j.lrr.2025.100548.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.